Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

Clustered regulatory interspaced short palindromic repeats (CRISPR) has changed biomedical research and provided entirely new models to analyze every aspect of biomedical sciences during the last decade. In the study of cancer, the CRISPR/CRISPR-associated protein (Cas) system opens new avenues into...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussen, Bashdar Mahmud, Rasul, Mohammed Fatih, Abdullah, Snur Rasool, Hidayat, Hazha Jamal, Faraj, Goran Sedeeq Hama, Ali, Fattma Abodi, Salihi, Abbas, Baniahmad, Aria, Ghafouri-Fard, Soudeh, Rahman, Milladur, Glassy, Mark C., Branicki, Wojciech, Taheri, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351202/
https://www.ncbi.nlm.nih.gov/pubmed/37460924
http://dx.doi.org/10.1186/s40779-023-00468-6

Ejemplares similares

Ejemplares similares